Home / General / J&J Prostate Cancer Drug Reduces Risk of Cancer Spread and Death in Late-Stage Study

J&J Prostate Cancer Drug Reduces Risk of Cancer Spread and Death in Late-Stage Study

US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.

By Sneha S K
May 31 (Reuters) – Johnson & Johnson’s prostate cancer drug Erleada ⁠used ⁠with hormone-blocking therapy six months before and ⁠after prostate surgery improved the chances of eliminating the cancer and reduced the risk of ​disease progre… [3112 chars]

Source: U.S. News & World Report | Published: 2026-05-31T12:01:00Z

Credit: U.S. News & World Report

Tagged: